1 not yet recruiting, 1 recruiting, 1 terminated. 1 Not applicable, 1 Phase 2, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Not yet recruiting 1 |
| Phase 2 | 1 | Terminated 1 |
| Phase 4 | 1 | Recruiting 1 |
Follow Azithromycin (Azithro): new trials by email Literature Review of Azithromycin (Azithro) trials Research Report on Azithromycin (Azithro)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Improving Management and Secondary Prevention Through Azithromycin Comparative Trial in Rheumatic Heart Disease in Nigeria)- IMPACT-RHD Nigeria Benzathine Penicillin, Azithromycin (Azithro) - Rheumatic Fever, Valvular Heart Diseases | Not applicable | Not yet recruiting | Ladoke Akintola University of Technology, Ogbomoso, Nigeria | 474 | 2027-01-05 | 2026-06-04 |
| Extended Azithromycin Treatment in Prelabor Rupture of Membranes Azithromycin (Azithro), Standard Azithromycin Dosing - Preterm Prelabor Rupture of Membranes, PPROM | Phase 4 | Recruiting | Alexa Henderson | 30 | 2026-08-19 | 2026-09-04 |
| Evaluating the Efficacy of Hydroxychloroquine and Azithromycin to Prevent Hospitalization or Death in Persons With COVID-19 Hydroxychloroquine (HCQ), Azithromycin (Azithro), Placebo for Hydroxychloroquine - COVID-19, SARS-CoV 2 | Phase 2 | Terminated | National Institute of Allergy and Infectious Diseases (NIAID) | 20 | 2020-05-13 | 2021-11-16 |
COVID-19 (1) · Heart Valve Diseases (1) · Preterm Premature Rupture of the Membranes (1) · Rheumatic Fever (1)
Alexa Henderson (1) · Ladoke Akintola University of Technology, Ogbomoso, Nigeria (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1)
United States (2)
Adeseye A Akintunde (1) · Christina Megli, MD/PhD (1) · Davey Smith, MD (1)